These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24982060)

  • 1. Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
    Kannengiesser C; Borie R; Revy P
    Eur Respir J; 2014 Jul; 44(1):269-70. PubMed ID: 24982060
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation.
    Fukuhara A; Tanino Y; Ishii T; Inokoshi Y; Saito K; Fukuhara N; Sato S; Saito J; Ishida T; Yamaguchi H; Munakata M
    Eur Respir J; 2013 Dec; 42(6):1757-9. PubMed ID: 24072216
    [No Abstract]   [Full Text] [Related]  

  • 3. From the authors.
    Tanino Y; Yamaguchi H; Fukuhara A; Munakata M
    Eur Respir J; 2014 Jul; 44(1):270-1. PubMed ID: 24982061
    [No Abstract]   [Full Text] [Related]  

  • 4. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita.
    Du H; Guo Y; Ma D; Tang K; Cai D; Luo Y; Xie C
    Medicine (Baltimore); 2018 May; 97(19):e0724. PubMed ID: 29742735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of dyskeratosis congenita-associated pulmonary fibrosis with danazol.
    Zlateska B; Ciccolini A; Dror Y
    Pediatr Pulmonol; 2015 Dec; 50(12):E48-51. PubMed ID: 26083318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vasculopathy in autosomal dominant dyskeratosis congenita due to TINF2 mutation.
    Gleeson M; O'Marcaigh A; Cotter M; Brosnahan D; Vulliamy T; Smith OP
    Br J Haematol; 2012 Dec; 159(5):498. PubMed ID: 23094712
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation.
    Isoda T; Mitsuiki N; Ohkawa T; Kaneko S; Endo A; Ono T; Aoki Y; Tomizawa D; Kajiwara M; Araki S; Nagasawa M; Morio T; Takagi M; Mizutani S
    J Pediatr Hematol Oncol; 2013 May; 35(4):e178-82. PubMed ID: 23242325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex.
    Sarper N; Zengin E; Kılıç SÇ
    Pediatr Blood Cancer; 2010 Dec; 55(6):1185-6. PubMed ID: 20979174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.
    Sasa GS; Ribes-Zamora A; Nelson ND; Bertuch AA
    Clin Genet; 2012 May; 81(5):470-8. PubMed ID: 21477109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.
    Alder JK; Stanley SE; Wagner CL; Hamilton M; Hanumanthu VS; Armanios M
    Chest; 2015 May; 147(5):1361-1368. PubMed ID: 25539146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia and pancytopenia caused by a mutation in TINF2.
    Tsangaris E; Adams SL; Yoon G; Chitayat D; Lansdorp P; Dokal I; Dror Y
    Hum Genet; 2008 Dec; 124(5):507-13. PubMed ID: 18979121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
    Pereboeva L; Hubbard M; Goldman FD; Westin ER
    PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
    Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
    J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyskeratosis congenital: clinical features and genotype analysis in two Chinese patients].
    Liu R; Shi XD; Wang TY; Liu ZQ; Hu T; Fan W; Cao J; Hou R; Liang C; Huang SA
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):684-7. PubMed ID: 22339828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An emerging role for the conserved telomere component 1 (CTC1) in human genetic disease.
    Armanios M
    Pediatr Blood Cancer; 2012 Aug; 59(2):209-10. PubMed ID: 22556055
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of interactions between naturally mutated forms of the TIN2 protein and its known protein partners of the shelterin complex.
    Xin ZT; Ly H
    Clin Genet; 2012 Mar; 81(3):301-2. PubMed ID: 22211879
    [No Abstract]   [Full Text] [Related]  

  • 17. Exudative Vitreoretinopathy in Dyskeratosis Congenita.
    Indaram M; Agarwal S; Yonekawa Y
    Ophthalmology; 2017 Aug; 124(8):1246. PubMed ID: 28734336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow failure due to telomere associated gene mutation].
    Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases.
    Dvorak LA; Vassallo R; Kirmani S; Johnson G; Hartman TE; Tazelaar HD; Leslie KO; Colby TV; Cockcroft DW; Churg AM; Yi ES
    Hum Pathol; 2015 Jan; 46(1):147-52. PubMed ID: 25455995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility.
    Koivuluoma S; Vorimo S; Mattila TM; Tervasmäki A; Kumpula T; Kuismin O; Winqvist R; Moilanen J; Mantere T; Pylkäs K
    Fam Cancer; 2023 Jan; 22(1):13-17. PubMed ID: 35590014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.